The Union Health Ministry has announced a major change regarding the sale of cough syrup and other syrup-based medicines in India. Under the new rule, people must now have a valid prescription from a registered doctor before buying these medicines. Pharmacies will no longer be allowed to sell such syrups directly over the counter.
The decision is aimed at improving patient safety and preventing the misuse of medicines. Health authorities believe that requiring a prescription will help ensure that people use these medicines correctly and only when medically necessary.
Union Health Ministry Updates Drug Rules
The new regulation follows an amendment to the Drugs Rules, 1945. The Central Government introduced the change through the Drugs (Fifth Amendment) Rules, 2026, which were officially published in the Gazette on June 9, 2026.
According to the amendment, the term “Syrups” has been removed from item number (7) under serial number 13 of Schedule K of the Drugs Rules. Schedule K contains a list of medicines that are exempt from certain regulatory requirements under the Drugs and Cosmetics Act, 1940.
With syrups no longer included in this exemption list, these medicines will now be subject to stricter regulatory controls. This means they can only be sold after a doctor’s prescription is presented.
What Does the New Cough Syrup Rule Mean?
The latest rule changes how cough syrup and other medicinal syrups are sold across the country.
Prescription Now Mandatory
Under the new system, chemists and pharmacies must verify a valid prescription before selling syrup-based medicines. This requirement applies to all medicinal syrups that were previously available without a prescription. As a result, customers will no longer be able to walk into a pharmacy and purchase these medicines without medical approval.
End of Over-the-Counter Sales
For many years, cough syrups and liquid medicines were easily available at pharmacies without any prescription. While this offered convenience, it also increased the risk of self-medication and improper use. The latest move officially ends over-the-counter sales of these medicines and places them under stricter supervision.
How the Rule Was Introduced
Before implementing the amendment, the government released a draft notification on December 29, 2025. The draft invited suggestions and objections from stakeholders, industry representatives, and members of the public.
Officials reviewed the feedback received during the consultation period before finalizing the amendment. The government also discussed the proposal with the Drugs Technical Advisory Board before issuing the final notification. Following these consultations, the amendment was approved and formally added to the Drugs Rules, 1945.
Why Has the Union Health Ministry Taken This Decision?
The Union Health Ministry says the main objective is to reduce the misuse of medicinal syrups and encourage responsible use of medicines.
Concerns Over Self-Medication
Many people purchase cough syrups without consulting a doctor. In some cases, this can lead to incorrect dosages, delayed diagnosis of illnesses, and unnecessary health risks. Medical experts have long warned against self-medication, especially when medicines are taken without proper guidance. The new prescription requirement is expected to help address these concerns.
Protecting Children and Vulnerable Patients
Health authorities have also focused on ensuring the safe use of medicines among children and vulnerable groups. Incorrect use of syrup-based medicines can have serious consequences, particularly for young patients. By making prescriptions compulsory, regulators hope to ensure that medicines are used only under professional supervision.
Increased Focus on Medicine Safety
The decision comes at a time when regulators are paying closer attention to medicine quality and safety. In recent years, concerns have been raised globally about contaminated cough syrups and the need for stronger monitoring of pharmaceutical products. These incidents have encouraged authorities to tighten regulations and strengthen oversight of medicine manufacturing and distribution.
Impact on Consumers and Pharmacies
The new rule will affect both consumers and pharmacy owners. Patients will now need to visit a qualified doctor before purchasing syrup-based medicines. While this may add an extra step, health officials believe it will promote safer treatment and better medical care. Pharmacies, meanwhile, will be required to check prescriptions carefully before dispensing these medicines. Failure to comply with the rules could lead to regulatory action.
